Home / Events /

Almac Sciences is delighted to be exhibiting and speaking at the 8th International Neoantigen Summit 2025, taking place from the 24th – 26th June 2025 in Amsterdam, Netherlands.

About 8th International Neoantigen Summit

2024 saw a wealth of clinical progression with Nouscom, CureVac, Transgene and other pioneering companies paving the way for neoantigen based vaccines and therapies to become tolerable, durable medicines to effectively treat cancer. Ready to unite the global neoantigen community, the 8th International Neoantigen Summit returns to address key challenges in the discovery, translation and clinical development of safe and cost-effective neoantigen therapies and vaccines to attract investors and ultimately improve the health of patients.

For more information and to register for the event, please visit the International Neoantigen Summit website.

Share this event

Share on Facebook Share on Twitter Share on LinkedIn
Alastair Hay

Alastair Hay

Vice President | Peptides

Email

Vice President | Peptides

Simon Hamilton

Simon Hamilton

Head of Business Development

Email

Head of Business Development | Almac Sciences

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies